Forbion European Acquisition has entered a definitive business combination agreement with biotechnology company enGene to create a combined biotechnology company to develop next-generation non-viral, locally administered gene therapies.
The combined …
VIEW ARTICLE
If you would like to know more regarding the topic in this blog post, please do not hesitate to contact us.
